InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Wiley Matthew T., Directeur Commercial. Officer active across 1 company, notably VYNE Therapeutics Inc.. Cumulatively, 2 filings have been recorded. History available since 30 June 2021. The latest transaction was filed on 30 June 2021 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
5,151 shares@ US$3.510.079% mcap50.0% of flowCommon StockSEC:0001209191-21-044980:0
5,151 shares@ US$3.510.079% mcap100.0% of flowCommon StockSEC:0001209191-21-044980
2 of 2 declarations
About Wiley Matthew T.
Wiley Matthew T. serves as the Chief Commercial Officer at VYNE Therapeutics Inc. In this role, he is responsible for the company's commercial strategy, including developing new markets and optimizing sales. Matthew plays a key role in building customer relationships and promoting VYNE Therapeutics' products, thereby contributing to the company's growth.
